Stay updated on PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page.
Latest updates to the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedOtsuka Pharmaceutical Development & Commercialization, Inc. has been added, while Sumitomo Pharma America, Inc. has been removed.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check46 days agoChange DetectedResults have been posted on November 25, 2024, replacing the previous status of results submitted on June 28, 2023.SummaryDifference1%
- Check53 days agoChange DetectedThe website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.SummaryDifference13%
Stay in the know with updates to PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET Imaging of Antipsychotic Adjunct in Schizophrenia Clinical Trial page.